CRSP vs NOK · rev $11.6M vs P/E 87, $78.04B cap
Crispr Therapeutics AG (CRSP) versus Nokia Corp ADR (NOK) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Nokia Corp ADR (NOK) is a communication equipment company listed on NYSE. It is led by Justin Hotard.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
NOK does not have a complete income-statement cache yet.
CRSP currently screens at market cap $5.42B. NOK currently screens at market cap $78.04B and trailing P/E 87.4.
Not investment advice. Open the CRSP and NOK stock pages for the full models.
Not investment advice.